help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Journal of Clinical Endocrinology & Metabolism Vol. 67, No. 6 1117-1121
doi:10.1210/jcem-67-6-1117
Copyright © 1988 by the Endocrine Society.
This Article
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by OZTURK, M.
Right arrow Articles by WANDS, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by OZTURK, M.
Right arrow Articles by WANDS, J.

Physiological Studies of Human Chorionic Gonadotropin and Free Subunits in the Amniotic Fluid Compartment Compared to Those in Maternal Serum*

MEHMET OZTURK, NANCY BROWN, AUBREY MILUNSKY and JACK WANDS{dagger}

Molecular Hepatology Laboratory, MGH Cancer Center, Massachusetts General Hospital, and the Department of Medicine, Harvard Medical School Charlestown, Massachusetts 02129
the Center for Human Genetics and the Department of Pediatrics, Boston University School of Medicine (A.M.) Boston, Massachusetts 02118

Address all correspondence and requests for reprints to: Mehmet Ozturk, Ph.D., Molecular Hepatology Laboratory, MGH Cancer Center, MGH East, 149 13th Street, Charlestown Massachusetts 02129.

We measured intact hCG, free {alpha}hCG, and free βhCG levels in amniotic fluid and maternal serum using specific monoclonal antibody-based immunoradiometric assays. Compared to maternal serum, amniotic fluid had low levels of intact hormone along with high levels of its free subunits. The mean amniotic fluid hCG level was 1 mg/L at 13 weeks, and it progressively decreased to 0.100 mg/L by the 23rd week. Amniotic fluid {alpha}hCG levels were highest at 15 and 16 weeks (0.340 mg/L) and rapidly declined to concentrations less than 0.050 mg/L at 21 weeks. Amniotic fluid βhCG concentrations were about 0.200 mg/L between 13 and 16 weeks and progressively decreased until the 23rd week. In vitro stability studies of hCG and its subunits demonstrated that dissociation of hCG into its subunits was not responsible for these results. Both hCG and free subunits detected in amniotic fluid were indistinguishable from standard hCG and free subunit preparations, as analyzed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis. Our findings are consistent with the hypothesis that the presence of hCG and free subunits in the amniotic fluid represents secretion from the trophoblastic tissue into the amniotic fluid compartment. Furthermore, high serum hCG levels in association with low levels of its free subunits are probably the result of polarized secretion of the intact hormone from the syncytiotrophoblasts into the maternal circulation.

* This work was supported in part by Grants HD-20469, CA-35711, and AA-20666 from the NIH.

{dagger} Recipient of a Research Career Scientist Development Award AA-00048 from the NIH.

Received February 8, 1988.




This article has been cited by other articles:


Home page
Hum Reprod UpdateHome page
C. Ferretti, L. Bruni, V. Dangles-Marie, A.P. Pecking, and D. Bellet
Molecular circuits shared by placental and cancer cells, and their implications in the proliferative, invasive and migratory capacities of trophoblasts
Hum. Reprod. Update, March 1, 2007; 13(2): 121 - 141.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
M. A. Abdallah, Z. M. Lei, X. Li, N. Greenwold, S. T. Nakajima, E. Jauniaux, and Ch. V. Rao
Human Fetal Nongonadal Tissues Contain Human Chorionic Gonadotropin/Luteinizing Hormone Receptors
J. Clin. Endocrinol. Metab., February 1, 2004; 89(2): 952 - 956.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
B. Couzinet, J. Pantel, P. Chanson, J. Young, S. Brailly, I. T. Huhtaniemi, J.-M. Bidart, and G. Schaison
Measurement of Plasma Free Luteinizing Hormone {beta}-Subunit in Women
J. Clin. Endocrinol. Metab., June 1, 2000; 85(6): 2293 - 2298.
[Abstract] [Full Text]


Home page
Hum ReprodHome page
O. Ogueh, J. Jones, H. Mitchell, J. Alaghband-Zadeh, and M.R. Johnson
Effect of antenatal dexamethasone therapy on maternal plasma human chorionic gonadotrophin, oestradiol and progesterone
Hum. Reprod., February 1, 1999; 14(2): 303 - 306.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
J. Korhonen, H. Alfthan, P. Ylostalo, J. Veldhuis, and U.-H. Stenman
Disappearance of human chorionic gonadotropin and its {alpha}- and ß-subunits after term pregnancy
Clin. Chem., November 1, 1997; 43(11): 2155 - 2163.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
P. Chanson, J. Pantel, J. Young, B. Couzinet, J.-M. Bidart, and G. Schaison
Free Luteinizing-Hormone Beta-Subunit in Normal Subjects and Patients with Pituitary Adenomas
J. Clin. Endocrinol. Metab., May 1, 1997; 82(5): 1397 - 1402.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1988 by The Endocrine Society